CORVUS PHARMACEUTICALS INC (CRVS)
Sector: Health Care
Named Executive Officers
Compensation data for top executives (showing up to 3 years of data)
| Executive | Year | Salary | Bonus | Stock Awards | Option Awards | Non-Equity Incentive Comp | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Richard A. Miller, M.D. President and Chief Executive Officer | 2025 | $36,566 | $0 | $0 | $6,989,000 | $0 | $6,000 | $7,031,566 |
| 2024 | $32,675 | $0 | $0 | $3,034,495 | $0 | $6,000 | $3,073,170 | |
| 2023 | $110,309 | $0 | $0 | $0 | $1,205,042 | $6,000 | $1,321,351 |
| Executive | Year | Salary | Bonus | Stock Awards | Option Awards | Non-Equity Incentive Comp | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Leiv Lea Chief Financial Officer | 2025 | $405,948 | $0 | $0 | $2,795,600 | $0 | $6,000 | $3,207,548 |
| 2024 | $394,655 | $0 | $0 | $1,213,798 | $0 | $6,000 | $1,614,453 | |
| 2023 | $394,213 | $0 | $0 | $0 | $260,551 | $6,000 | $660,764 |
| Executive | Year | Salary | Bonus | Stock Awards | Option Awards | Non-Equity Incentive Comp | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| William B. Jones, Ph.D. Senior Vice President, Pharmaceutical Development | 2025 | $360,115 | $0 | $0 | $2,795,600 | $0 | $6,000 | $3,161,715 |
| 2024 | $350,097 | $0 | $0 | $1,213,798 | $0 | $6,000 | $1,569,895 | |
| 2023 | $349,705 | $0 | $0 | $0 | $260,551 | $6,000 | $616,256 |